Vaso Corporation

Equities

VASO

US92233F1021

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 15:47:16 2024-05-29 EDT			5-day change	1st Jan Change
0.2559 ^USD	+0.35%		-3.40%	-16.10%

05-15	Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-01	Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Vaso Corporation Announces Earnings Results for the First Quarter Ended March 31, 2021

June 04, 2021 at 03:18 pm

Vaso Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 16.519 million compared to USD 17.227 million a year ago. Operating loss was USD 539,000 compared to USD 1.360 million a year ago. Net loss was USD 643,000 compared to USD 1.475 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago.

Latest news about Vaso Corporation

Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Vaso Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04-01	CI
Vaso Corporation entered into a business combination agreement to acquire Achari Ventures Holdings Corp. I from Achari Sponsor Holdings I LLC and others for approximately $190 million in a reverse merger transaction.	12-06	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Vaso Corporation Appoints Leon Dembo as Independent Director	23-04-03	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Vaso Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Vaso Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Vaso Corporation Receives Confirmation That the Small Business Administration Approves the Company's PPP Note Forgiveness Application	21-06-25	CI
Vaso Corporation Announces Earnings Results for the First Quarter Ended March 31, 2021	21-06-04	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-05	CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Vaso : Earnings Flash (VASO) VASO CORPORATION Posts Q3 Revenue $17.5M	20-11-13	MT
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14	CI
Vaso Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Vaso Corporation Names Jane Moen as Class II Director	20-03-31	CI
Vaso Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Vaso Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI

Chart Vaso Corporation

Duration

Period

More charts

Company Profile

Vaso Corporation is principally engaged in operating the healthcare equipment and information technology industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment operates through a wholly owned subsidiary, VasoTechnology, Inc., which primarily focuses on healthcare information technology (IT) and managed network technology services. Its Professional sales service segment operates through a wholly owned subsidiary, Vaso Diagnostics, Inc. doing business as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare (GEHC) into the health provider middle market. Its Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through the Company's subsidiary, VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
VASO CORPORATION	-16.10%	44.71M
THERMO FISHER SCIENTIFIC	+6.88%	219B
DANAHER CORPORATION	+10.63%	192B
INTUITIVE SURGICAL, INC.	+18.16%	142B
BOSTON SCIENTIFIC CORPORATION	+29.70%	111B
SIEMENS HEALTHINEERS AG	+2.09%	65.32B
EDWARDS LIFESCIENCES CORPORATION	+14.14%	52.45B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.01%	49.8B
AGILENT TECHNOLOGIES, INC.	+4.64%	43.43B
GE HEALTHCARE TECHNOLOGIES INC.	+1.45%	35.95B

Other Advanced Medical Equipment & Technology